https://www.europeanpharmaceuticalreview.com/news/177879/stem-cell-transplants-may-slow-disability-progression-in-ms/
0
0
12/22/22 at 8:15am
Organization
European Pharmaceutical Review
30 words
0
Comments
Stem cell transplants may delay disability longer than other medications in patients with active secondary progressive multiple sclerosis.
You are the first to view
Create an account
or login to join the discussion